Tranexamic acid has been shown to reduce rebleeding after aneurysmal subarachnoid
hemorrhage; however, whether it can reduce mortality and improve clinical outcomes is …

Tranexamic Acid for Prevention and Treatment of Postpartum H... : Obstetrical &
Gynecological Survey Tranexamic Acid for Prevention and Treatment of Postpartum …

Introduction Adolescence is a critical period characterized by significant physical, emotional,
cognitive, and social changes, including the monthly occurrence of menstruation of …

Background: Tranexamic acid (TA) has been demonstrated to reduce blood loss and the
incidences of postpartum hemorrhage (PPH) during caesarean sections. We compared the …

Aim Tranexamic acid (TXA) has been used to treat peripartum hemorrhage, while
preoperative use of TXA in cesarean section (CS) remains controversial. To assess the …

Background Africa is a developing continent with a high maternal mortality rate. It is
beneficial to implement interventions that alleviate the problem. As a result, this systematic …

BackgroundPostpartum hemorrhage (PPH) is one of the leading causes of maternal
mortality and morbidity worldwide. It is believed that hemostatic imbalance secondary to …

The ability of ultrasound to predict postpartum hemorrhage remains poorly described. The
aim of this study was to evaluate whether ultrasound measurement of intrauterine content …

Postpartum haemorrhage (PPH) is a leading cause of maternal morbidity and mortality.
While tranexamic acid (TXA) reduces bleeding and transfusion requirements in established …

Background & aim: Cesarean section (CS) results in about twice the blood loss as
vaginal delivery. Blood loss can cause decreased hemoglobin and hematocrit. Few studies …